Sézary syndrome patient-derived models allow drug selection for personalized therapy.
Gallardo F, Andrades E, Iglesias A, González J, Solé L, Guillén Y, Blanco G, Colomo L, Gimeno E, Conde D, Rodriguez E, Bielsa-Marso I, Iglesias M, Bellosillo B, Pujol RM, Regueiro JR, Bigas A, Espinosa L.
Gallardo F, et al.
Blood Adv. 2022 Jun 14;6(11):3410-3421. doi: 10.1182/bloodadvances.2021006860.
Blood Adv. 2022.
PMID: 35413113
Free PMC article.